Search

Your search keyword '"Zichichi, L"' showing total 56 results

Search Constraints

Start Over You searched for: Author "Zichichi, L" Remove constraint Author: "Zichichi, L"
56 results on '"Zichichi, L"'

Search Results

1. Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study

2. Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis)

3. Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study

4. The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates

5. Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry*

7. Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study

8. Pruritus characteristics in a large Italian cohort of psoriatic patients

9. Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis. results from extension phase of the SUPREME study

10. From the Aosta Valley to Sicily: Differences in Clinico-Pathologic Features and Distribution of Risk Factors in Italian Melanoma Patients: A Multicenter Survey from the GIPME: P-013

11. Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study

12. Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis. SUPREME study

13. Centrality, rapidity and transverse momentum dependence of J/ψ suppression in Pb–Pb collisions at √sNN = 2.76 TeV

14. Familial and sporadic melanoma: different clinical and histopathological features in the Italian population - a multicentre epidemiological study - by GIPMe (Italian Multidisciplinary Group on Melanoma)

15. Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry

16. Mongolian spot. Incidence and natural history in western Sicily

17. Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: Evidence from the Italian Psocare Registry

18. Differences in Clinicopathological Features and Distribution of Risk Factors in Italian Melanoma Patients

20. Mycosis fungoides: disease evolution of the 'lion queen' revisited

21. Mycosis fungoides: Disease evolution of the 'lion queen' revisited

22. Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.

23. From the Aosta Valley to Sicily: Differences in Clinico-Pathologic Features and Distribution of Risk Factors in Italian Melanoma Patients: A Multicenter Survey from the GIPME

24. Desloratadine 5 mg once daily improves quality of life in chronic idiopathic urticaria

25. Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients

26. Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing

27. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study

28. Latent tubercolosis infection in patients with cronic plaque psoriasis: evidence from the Italian Psocare Registry

29. Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas

30. The Challenges of Managing Psoriasis on the Ear.

31. Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.

32. Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis).

34. EMPATHY Life in Psoriasis: Embracing Patients' Well-Being in Their Journey of Moderate-to-Severe Psoriasis.

36. Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis.

37. Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis.

38. Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus.

39. Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study.

40. Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing.

41. Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.

42. Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial.

43. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.

44. Paget's disease of scrotum and penis case report of a re-irradiation and review of the literature.

45. Analysis of Sentinel Node Biopsy and Clinicopathologic Features as Prognostic Factors in Patients With Atypical Melanocytic Tumors.

46. Skin and diabetes: an experts' opinion from the Italian diabetologists and dermatologists of the DiaDex group.

47. Mycosis fungoides: disease evolution of the "lion queen" revisited.

48. The challenges of a neglected STI: Molluscum contagiosum.

49. Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

50. Multifocal cutaneous leishmaniasis: a new clinical presentation of the disease.

Catalog

Books, media, physical & digital resources